2022
DOI: 10.1016/j.adro.2021.100865
|View full text |Cite
|
Sign up to set email alerts
|

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 24 publications
1
16
0
Order By: Relevance
“…Similar differences, i.e. slightly higher target coverages and lower OAR doses, were also observed in mCycle validation studies [8] , [21] , [23] .…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…Similar differences, i.e. slightly higher target coverages and lower OAR doses, were also observed in mCycle validation studies [8] , [21] , [23] .…”
Section: Discussionsupporting
confidence: 81%
“…While no fully automated treatment planning is yet available for clinical use on the MR-Linac, the vendor Elekta AB has developed a feature to allow autoplanning in a research setting [8] , [21] , [23] , called mCycle.…”
Section: Methods/materialsmentioning
confidence: 99%
“…Over the past decade several such systems have been proposed, e.g. knowledge-based planning (KBP), multi-criteria optimization (MCO), template-based approaches and particle swarm optimization [1] , [2] , [3] , [4] , [5] , [6] , [7] . All of these tend to reduce the inter-planner variability, decrease the time spent on the optimization procedure and improve the plan quality.…”
Section: Introductionmentioning
confidence: 99%
“…A completely new code has been written to embed this approach in the Monaco environment with a different mathematical solver, a different patient model, the typical Monaco cost functions, and a Monte Carlo Algorithm (XVMC) ( 8 ). The published experiences are mainly focused on iCycle application in several anatomic sites, while applications of the novel mCycle are reported only for head and neck, prostate and rectal cancer volumetric-modulated arc therapy (VMAT) treatment planning ( 8 , 9 ), and prostate treatment on an MR-Linac ( 10 ). This is the first feasibility study of mCycle implementation for cervical cancer treatment.…”
Section: Introductionmentioning
confidence: 99%